Akbarzadeh I,Shayan M,Bourbourm M,Moghtaderi M,Noorbazargan H,Eshrati Yeganeh F,Saffar S,Tahriri M .2021 .Preparation, optimization, and in-vitro evaluation of curcumin-loaded niosome@ calcium alginate nanocarrier as a new approach for breast cancer treatment. Biol, 10(2) : 1-27.
Akhter K,Ullah K,Talat R,Haider A,Khalid N,Ullah F,Ali S .2019 .Synthesis and characterization of cationic surfactants and their interactions with drug and metal complexes. Heliyon, 5(6) : 1-8.
Alajmi AA,Al Otaibi SG,Alzubidi AHA,Alanazi AAA,Abdullah SA,Alrbian AAM .2023 .Advancements in nanomedicine: Targeted drug delivery systems for cancer treatment. Intl J. of Health Sci., 7(1) : 3655-3682.
Ali MA,Aiman W,Shah SS,Hussain M .2021 .Kashyap R. Efficacy and safety of Pembrolizumab based therapies in triple-negative breast cancer: A systematic review of clinical trials. Critical Reviews in Oncol/ Hematol, 157 : 103-197.
Amin M,Seynhaeve ALB,Sharifi M,Falahati M,Ten Hagen TLM .2022 .Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience. , 14(10) : 2165.
Assikis VJ,Buzdar A .2002 .Recent advances in aromatase inhibitor therapy for breast cancer. , 29(3) : 120-128.
Barani M,Mirzaei M,Torkzadeh-Mahani M,Nematollahi MH .2018 .Lawsone-loaded Niosome and its antitumor activity in MCF-7 breast Cancer cell line: a Nano-herbal treatment for Cancer. , 26(1) : 11-17.
Beer TM,AJ TM .2014 .Enzalutamide in metastatic prostate cancer before chemotherapy. New England J Med, 371(5) : 424-433.
Bergsland E,Dickler MN .2004 .Maximizing the potential of bevacizumab in cancer treatment. The Oncol., 9(Suppl, 1 : 36-42.
Bhardwaj P,Tripathi P,Gupta R,Pandey S,Part A .2020 .Niosomes: A review on niosomal research in the last decade. J of Drug Deliver Sci and Technol, 101581 : .
Bonifazi M,Franchi M,Rossi M,Moja L,Zambelli A,Zambon A,Corrao G,La Vecchia C,Zocchetti C,Negri E .2013 .Trastuzumab-related cardiotoxicity in early breast cancer: a cohort study. Oncologist, 18(7) : 795-801.
Danaei M,Dehghankhold M,Ataei S,Hasanzadeh Davarani F,Javanmard R,Dokhani A,Khorasani S,Mozafari MR .2018 .Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. , 18(2) : 57.
Darson J,Thirunellai Seshadri,Katariya R,Mohan K,Kamath M,Etyala MS,Chandrasekaran MA,G MA .2023 .Design development and optimisation of multifunctional Doxorubicin-loaded Indocynanine Green proniosomal gel derived niosomes for tumour management. Sci Rep., 13 : 1697.
Deininger MW,Druker BJ .2003 .Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev., 55(3) : 401-423.
Druker BJ,Tamura S,Buchdunger E .2001 ."Effects of a selective inhibitor of the BCRABL tyrosine kinase on the growth of BCR-ABL-positive cells. " Nature Med, 7(6) : 663-669.
El-Ela F IA,Gamal A,Elbanna HA,Tulbah HF,AS HF .2022 .In vitro and in vivo evaluation of the effectiveness and safety of amygdalin as a cancer therapy. Pharmaceut, 15(11) : 1306.
Fadaei MS,Fadaei MR,Kheirieh AE,Rahmanian-Devin P,Dabbaghi MM,Tavallaei KN,Shafaghi A,H A,Nokhodchi VB,Askari A,VR A .2024 .Niosome as a promising tool for increasing the effectiveness of anti-inflammatory compounds. EXCLI J, 23 : 212.
Fahmy SA,Ramzy A,Sawy AM,Nabil M,Gad MZ,El-Shazly M,Aboul-Soud MAM,Azzazy HM .2022 .Ozonated Olive Oil: Enhanced Cutaneous Delivery via Niosomal Nanovesicles for Melanoma Treatment. , 11 : 1318.
Fan D,Cao Y,Cao M,Wang Y,Cao Y,Gong T .2023 .Nanomedicine in cancer therapy. Signal Transduct Target Ther., 8(1) : 293.
Amandi Firouzi,Bahmanyar A,Dadashpour Z,M Z .2024 .Fabrication of magnetic niosomal platform for delivery of resveratrol: Potential anticancer activity against human pancreatic cancer Capan-1 cells. Cancer Cell Intl. , 24 : 46.
Fong PC,Boss D,Yap TA .2009 .Inhibition of poly (ADP-ribose) polymerase in tumors from BRCA mutation carriers. New England J Med, 361(2) : 123-134.
Gaikwad DS,Chougale RD,Patil KS,Disouza JI,Hajare AA .2023 .Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer. Future Journal of Pharm Sci., 9(1) : 43.
Galluzzi L,Senovilla L,Vitale I,Michels J,Martins I,Kepp O,Kroemer G .2012 .Molecular mechanisms of cisplatin resistance. Oncogene, 31(15) : 1869-1883.
Georg V .2020 .The Mechanism of Action of Cyclophosphamide and Its Consequences for the Development of a New Generation of Oxazaphosphorine Cytostatics. Sci Pharm., 88(4) : 42.
Ghode PD,Shweta P,Ghode P .2021 .Niosomes as Modern Drug Carrier Systems: Concepts and Advancements. Int J Med Phar Sci., 11(2) : 1-8.
Hajizadeh MR,Maleki H,Barani M,Fahmidehkar MA,Mahmoodi M,Torkzadeh-Mahani M .2019 .. Res Pharm Sci., 14 : 448.
Hamimed S,Jabberi M,Chatti A .2022 .Nanotechnology in drug and gene delivery. Naunyn Schmiedebergs Arch Pharmacol., 395(7) : 769-787.
Hu C,Rhodes DG .2000 .Proniosomes: A novel drug carrier preparation. Intl J Pharm., 206(1-2) : 110-122.
Huang J,Ssentongo P,Sharma R .2023 .Editorial: Cancer burden, prevention and treatment in developing countries. Front Public Health, 10 : 1124473.
Jordan VC .2007 .New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer. Steroids, 72(13) : 829-842.
Jordan .2004 .Microtubules as a target for anticancer drugs. Nature Reviews Cancer, 4(4) : 253-265.
Judy E,Lopus M,Kishore N .2021 .Mechanistic insights into encapsulation and release of drugs in colloidal niosomal systems: Biophysical aspects. RSC Adv, 11(56) : 35110-35126.
Kantarjian HM,O'Brien S,Gattermann N .2006 .Decitabine improves survival in patients with acute myeloid leukemia. Cancer, 107(3) : 506-514.
Kaur S,Kumari A,Kumari Negi A,Galav V,Thakur S,Agrawal M,Sharma V .2021 .Nanotechnology based approaches in phage therapy: overcoming the pharmacological barriers. , 12 : 699054.
Kauslya A,Borawake PD,Shinde JV,Chavan RS .2021 .Niosomes: A Novel Carrier Drug Delivery System. J. Drug Delivery Ther, 11(1) : 162-70.
Kciuk M,Gielecińska A,Mujwar S,Kołat D,Kałuzińska-Kołat Ż,Celik I,Kontek R .2023 .Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity. Cells, 12(4) : 659.
Khan MI,Madni A,Peltonen L .2016 .Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. Eur J Pharm Sci., 95 : 88-95.
Khan R,R R .2016 .Niosomes: A Potential Tool for Novel Drug Delivery. Journal of Pharmaceutical Investigation, 46 : 195-204.
Kolate A,Baradia D,Patil S,Vhora I,Kore G,Misra A .2014 .PEG - A versatile conjugating ligand for drugs and drug delivery systems. J. of Controlled Release, 192 : 67-81.
Koshani R,Jafari SM .2019 .Ultrasound-assisted preparation of different nanocarriers loaded with food bioactive ingredients. Adv Colloid Interface Sci, 270 : 123-146.
Kumar V,Bansal V,Madhavan A,Kumar M,Sindhu R,Awasthi MK Saran S .2022 .Active pharmaceutical ingredient [API] chemicals: A critical review of current biotechnological approaches. Bioengineered, 13(2) : 4309-4327.
Kumbhar D,Wavikar P,Vavia P .2013 .Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity. AAPS Pharm Sci Tech., 14(3) : 1072-82.
Kusdemir BC,Kozgus Guldu O,Yurt Kilcar A,Medine EI .2023 .Preparation and in vitro investigation of prostate-specific membrane antigen targeted lycopene loaded niosomes on prostate cancer cells. Intl J of Pharm., 640 : 123013.
Lalam ZA,Tafvizi F,Naseh V,Salehipour M .2022 .Characterization and optimization of co-delivery farnesol-gingerol niosomal formulation to enhance anticancer activities against breast cancer cells. J Drug Delv Sci Technol., 72 : 103371.
Lasic DD .1998 .Novel applications of liposomes. Trends Biotechnol, 16(7) : 307-21.
Li S,Chen L,Fu Y .2023 .Nanotechnology-based ocular drug delivery systems: Recent advances and future prospects. J. Nanobiotechnol., 21(1) : 232.
Liga S,Paul C,Moacă EA,Péter F .2024 .Niosomes: Composition, Formulation Techniques, and Recent Progress as Delivery Systems in Cancer Therapy. Pharmaceutics, 16(2) : 223.
Liu G,Yang L,Chen G,Xu F,Yang F,Yu H,Li L,Dong X,Han J,Cao C,Qi J,Su J,Xu X,Li X,Li B .2021 .A Review on Drug Delivery System for Tumor Therapy. , 12 : 735446.
Lohumi A .2012 .A novel drug delivery system: Niosomes review. J. Drug Deliv. Ther., 2 : 130-134.
Longley DB,Harkin DP,Johnston PG .2003 ."5-Fluorouracil: mechanisms of action and clinical strategies.". Nature Rev. Cancer, 3(5) : 330-338.
Mahale NB,Mali PD,Walunj RG,Chaudhari DR,SR DR .2012 .Niosomes: Novel sustained release nonionic stable vesicular systems - An overview. Adv in Colloid and Interface Sci, 183 : 46-54.
Manosroi A,Chutoprapat R,Abe M,Manosroi J .2008 .Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid. Int J Pharm., 352(1-2) : 248-55.
Marino P,Mininni M,Deiana G,Marino G,Divella R,Bochicchio I,Giuliano A,Lapadula S,Lettini AR,Sanseverino F .2024 .Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer. , 16(6) : Pp800.
Masoudi M,Gopalan R .2023 .Cancer stem cells in drug resistance and recurrence. , 15(2) : Pp542.
Maude SL,Laetsch TW,Buechner J .2018 .Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. New England J of Med, 378(5) : 439-448.
Mawazi SM,Ge Y,Widodo RT .2025 .Niosome Preparation Techniques and Structure-An Illustrated Review. , 17(1) : 67.
Moammeri A,Chegeni MM,Sahrayi H,Ghafelehbashi R,Memarzadeh F,Mansouri A,Akbarzadeh I,Abtahi MS,Hejabi F,Ren Q .2023 .Current advances in niosomes applications for drug delivery and cancer treatment. Mater, 23 : 100837.
Moghassemi S,Hadjizadeh A .2014 .Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release, 185 : 22-36.
Mohanty R,Chowdhury CR,Arega S,Sen P,Ganguly P,Ganguly N .2019 .CAR T cell therapy: A new era for cancer treatment. Oncology reports, 42(6) : 2183-2195.
Muzzalupo R,Mazzotta E .2019 .Do niosomes have a place in the field of drug delivery? Expert Opinion Drug Deliv. , 16(11) : 1145-1147.
Mythili L,Ganesh C,Kayalvizhi R C .2019 .. Ocular Drug Delivery System - An update Review. Res J. Pharm and Tech., 12(5) : 2527-2538.
Newman DJ,Cragg GM . .Natural products as sources of new drugs over the last 25 years. J Nat Prod., 70(3) : 461-477.
Okafo SE,Ordu J I,Ofagbor G,Agbamu E .2023 .Evaluation of physicochemical, in vivo analgesic and antiinflammatory activities of Brachystegia eurycoma gum-based naproxen loaded niosomal gels. Ger J Pharm Biomater., 2(1) : 26-37.
Palumbo A,Rajkumar SV,Harousseau JL .2008 .Combined therapy with bortezomib and dexamethasone for multiple myeloma. New England J of Med, 359(6) : 654-664.
Pandey P,Pal R,Khadam VKR,Chawra HS,Singh RP .2024 .Advancement and Characteristics of Non-Ionic Surfactant Vesicles (Niosome) and their Application for Analgesics. Int. J. Pharm. Investig., 4(3) : 616-632.
Primavera R,Palumbo P,Celia C,Cinque B,Carata E,Carafa M,Paolino D,Cifone MG,Di Marzio MG .2018 .An insight of in vitro transport of PEGylated non-ionic surfactant vesicles (NSVs) across the intestinal polarized enterocyte monolayers. European J of Pharm and Biopharm, 127 : 432-42.
Raut DJ,Shirode DS,Deokar SS,Saoji VV,Rajput GD,Deore MR,Powar PV .2023 .Latin American Journal of Pharmacy: A Life Sci. , 42(3) : 347-354.
Saha U,De R,Das B .2023 .Interactions between loaded drugs and surfactant molecules in micellar drug delivery systems: A critical review. J of Mol. Liquids, 382 : 121906.
Salem HF,Kharshoum RM,Abou-Taleb HA,Farouk HO,Zaki RM .2021 .Fabrication and appraisal of simvastatin via tailored niosomal nanovesicles for transdermal delivery enhancement: In vitro and in vivo assessment. Pharmaceutics, 13(2) : 138.
Santucci C,Carioli G,Bertuccio P,Malvezzi M,Pastorino U,Boffetta P .2020 .Progress in cancer mortality, incidence, and survival: A global overview. Eur J. Cancer Prev, 29 : 367-81.
Shafiei G,Jafari-Gharabaghlou D,Farhoudi-Sefidan-Jadid M,Alizadeh E,Fathi M,Zarghami N .2023 .Targeted delivery of silibinin via magnetic niosomal nanoparticles: Potential application in treatment of colon cancer cells. Frontr in Pharmacol., 14 : 1174120.
Shahbazi R,Jafari-Gharabaghlou D,Mirjafary Z,Saeidian H,Zarghami N .2023 .Design and optimization of various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: Potential anti-cancer effects against human lung cancer cells. Pharmacol Reports, 75(2) : 442-455.
Shrestha B,Tang L,Hood RL .2022 .Nanotechnology for Personalized Medicine. , 48 : Pp1.
Slamon DJ,Leyland-Jones B,Shak S .2001 .Use of chemotherapy plus trastuzumab (Herceptin) to treat women with HER2-positive breast cancer. New England J of Med, 344(11) : 783-792.
Iacob AT,Ababei-Bobu A,Chirliu OM,Lupascu FG,Vasincu IM,Apotrosoaei M,Profire BS,Tauser GR,Lupascu D,Profire L .2025 .A State-of-the-Art Review on Recent Biomedical Application of Polysaccharide-Based Niosomes as Drug Delivery Systems. , 17(11) : 1566.
Teron C,Bhuyan A,Saikia P,Dutta SR,Gogoi H,Rongpi S .2024 .A comprehensive review on niosomes in drug delivery and recent advancements. J of Drug Deliv and Therap, 14(6) : 262-273.
Topalian SL,Hodi FS,Brahmer JR .2012 .Safety, activity, and immune correlates of antiPD-1 antibody in cancer. New England J of Med, 366(26) : 2443-2454.
Uchegbu IF,Vyas SP .1998 .Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm., 172(1-2) : 33-70.
Van der Zanden SY,Qiao X,Neefjes J .2021 .New insights into the activities and toxicities of the old anticancer drug doxorubicin. The FEBS J., 288(21) : 6095-6111.
Von Arx C,De Placido P,Caltavituro A,Di Rienzo R,Buonaiuto R,De Laurentiis M,Del Mastro L .2023 .The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer. Cancer Treatment Rev., 113 : 102500.
Zaer M,Moeinzadeh A,Abolhassani H,Rostami N,Tavakkoli Yaraki M,Seyedi SA,Nabipoorashrafi SA,Bashiri Z,Moeinabadi-Bidgoli K,Moradbeygi F .2023 .Doxorubicin-loaded niosomes functionalized with gelatin and alginate as pHresponsive drug delivery system: A 3D printing approach. Intl J Biol Macromol., 253 : 126808.
Zhao X,Xie N,Zhang H,Zhou W,Ding J .2023 .Bacterial Drug Delivery Systems for Cancer Therapy: "Why" and "How". Pharmaceutics, 15 : 2214.
Zhen A,Zhang M,Liu F,Peng Q .2024 .Research progress of surface-active ionic liquids for drug delivery. J of Mol Liquids, 400 : 124546.
Zhu Y,Kuo MT,Jansen B .2008 ."Doxorubicin and its clinical applications." Cancer Res. , 68(10) : 429-434.